The Hartford (HIG)

Financieras / Seguros

Diversified insurer (Business Insurance, Personal Insurance, and Employee Benefits) trading at merely ~10.4× core earnings despite a return on capital near 18% and a combined ratio stable around 89-90%; the recent sale of Hartford Funds simplifies the business toward pure insurance but introduces transitory accounting noise in reported earnings that obscures underlying soundness.

Price
$137.88
as of 2026-08-25
Intrinsic value (5y, base)
$278
Total annual return (5y)
16.8%
15.1% price · 1.7% div
Status (nominal)
Very undervalued
Margin of safety
+42%

The essentials

  • Core net income of the last twelve months of US$3.87 billion with a return on capital of ~18.4%, within the excellent quality band (15-20%) and well above the 10% bar.
  • Exclusive license with AARP through 2032 for personal auto and home, and automated quotation tool ICON that resolves more than 75% of new small-business policies without human intervention.
  • Sale of Hartford Funds (agreed June 3, 2026) reclassifies that asset-management business as a discontinued operation across all periods, simplifying the profile toward a pure property-and-casualty and employee-benefits insurer.
  • Renewal price increases are moderating across small-business (from 6.5% in 2024 to 4.1% in Q2 2026) and home (from 12.6% to 10.4%), the signal to watch on the property-and-casualty insurance pricing cycle.
Source10-K FY2025Dec 31, 2025·DEF 14A 2026 (proxy)Apr 9, 2026·8-K Investor Financial SupplementJul 23, 2026·10-Q Q2 2026Jun 30, 2026
Health: Solid
Price$138as of 2026-08-25Market Cap$38.1 bnFloat / investments$0 bnP/book value2.0xCombined ratio89.9%Core ROE18.4%P/E (today)9.8x

Intrinsic value — two valuation methods

Margin of safety
Pricevalue today
$138
DCFvalue today
$399
+189.0% vs price
Multiplesvalue today
$236
+71.4% vs price

Total return at 5 years: 16.7%/year = 15.1% appreciation + 1.7% dividend. The target price ($278) is ex-dividend; the $15 in dividends collected over 5 years are added separately.

By both methods, the value today (DCF $399 · Multiples $236) exceeds the market price ($138).

Pillars of the analysis

The verdict — today vs 5 years

Today — with margin of safety: at $138 trades ~41.7% below its value discounted to today (~$236) — the wide discount we require (≥38%, equivalent to a ~15% annual return); the risk is covered by the margin, not the rate.

At 5 years — Muy infravalorado: the target price ($278) plus dividends yield above the required average return (10%) — the business compounds.

The bridge: the return at 5 years comfortably exceeds the risk-free rate (4.5%) — and the discount reaches the required margin of safety.

Thesis

The business

Upper-mid-quality diversified insurer, with return on capital (~18.4% core, GAAP ROE ~22.3%) clearly above the 10% bar and stable combined ratio (~89.9% TTM, ~88.5% underlying ex-catastrophes and reserve development). The sale of Hartford Funds simplifies the profile toward pure insurance, shedding an asset-management piece that provided revenue diversification but was not the core business.

The valuation

Valued by P/E on core net income (equity-level, already net of interest and taxes), with an exit multiple of 13.0× within the 11-15× band for the insurance archetype. The base case projects a value of $278 at five years, implying an estimated total return of +17% against market price.

The margin of safety

At current price of $138, the stock There is a margin of safety: the market's perception is meaningfully worse than reality.. The verdict Very undervalued reflects an entry multiple of merely ~10.4× core TTM earnings for a business with return on capital near 18%, a combination that rarely persists without market correction.

What to watch

The central disconfirmation is moderation of the underwriting pricing cycle: if renewal increases continue to fall (already at 4.1% in Small Business) without the combined ratio offsetting through efficiency, return on capital converges toward the 10% bar instead of sustaining near 18%. Also watch execution of the Hartford Funds sale and deployment of freed capital (accelerated buyback versus M&A).

Educational / informational. Does not constitute investment advice.